Riccardo Montioli Selected Research

Primary Hyperoxaluria (Oxaluria, Primary)

1/2016	Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
10/2015	The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I.
9/2015	Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.
11/2014	S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.
12/2013	Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
1/2012	Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
2/2010	Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.
1/2008	Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli.
11/2007	Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Riccardo Montioli Research Topics

Disease

9	Primary Hyperoxaluria (Oxaluria, Primary) 01/2016 - 11/2007
7	Gyrate Atrophy 02/2023 - 02/2014
5	Primary hyperoxaluria type 1 01/2016 - 03/2009
4	Parkinson Disease (Parkinson's Disease) 01/2016 - 12/2011
3	Inborn Genetic Diseases (Disease, Hereditary) 09/2021 - 01/2012
3	Rare Diseases (Rare Disease) 10/2015 - 02/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021 - 01/2012
2	Blindness (Hysterical Blindness) 01/2021 - 01/2017
2	Aromatic amino acid decarboxylase deficiency 10/2014 - 04/2013
1	Dystonia (Limb Dystonia) 12/2022
1	Neurologic Manifestations (Neurological Manifestations) 12/2022
1	Neoplasms (Cancer) 11/2017
1	Homocystinuria 02/2014
1	Hydroxykynureninuria 02/2014
1	Hypokinesia (Bradykinesia) 01/2012
1	Tremor (Tremors) 01/2012
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Schizophrenia (Dementia Praecox) 12/2011
1	Periodontitis 11/2006

Drug/Important Bio-Agent (IBA)

15	EnzymesIBA 02/2023 - 11/2007
11	Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA 01/2016 - 11/2007
10	PyridoxalIBA 01/2020 - 11/2006
4	Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)IBA 02/2023 - 01/2019
4	Aromatic-L-Amino-Acid DecarboxylasesIBA 12/2022 - 01/2012
4	Dopa DecarboxylaseIBA 12/2022 - 12/2011
4	OrnithineIBA 01/2021 - 01/2017
4	Transaminases (Aminotransferases)IBA 01/2021 - 01/2017
4	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 12/2011
4	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 12/2011
3	glyoxylic acid (glyoxylate)IBA 01/2016 - 01/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 12/2022 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 10/2015
2	OxalatesIBA 01/2016 - 03/2009
2	Calcium OxalateIBA 09/2015 - 12/2013
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 02/2014 - 04/2013
1	angiogeninIBA 09/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	5-fluoromethylornithineIBA 01/2019
1	SaltsIBA 01/2019
1	ranpirnase (Pannon)IBA 11/2017
1	Aromatic Amino Acid Decarboxylase InhibitorsIBA 01/2016
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2016
1	BenserazideIBA 01/2016
1	Levodopa (L Dopa)FDA LinkGeneric 01/2016
1	AcidsIBA 10/2015
1	Coenzymes (Enzyme Cofactors)IBA 02/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2010
1	Histidine (L-Histidine)FDA Link 01/2008
1	carbon-sulfur lyaseIBA 11/2006
1	Virulence Factors (Pathogenicity Factors)IBA 11/2006
1	cystalysinIBA 11/2006

Therapy/Procedure

1	Therapeutics 10/2014